ProPhase Labs, Inc. (PRPH) NASDAQ
0.12
-0.001(-0.80%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
0.12
-0.001(-0.80%)
Currency In USD
| Previous Close | 0.13 |
| Open | 0.11 |
| Day High | 0.15 |
| Day Low | 0.11 |
| 52-Week High | 6.7 |
| 52-Week Low | 0.07 |
| Volume | 22,600 |
| Average Volume | 194,583 |
| Market Cap | 587,389 |
| PE | -0.01 |
| EPS | -19.8 |
| Moving Average 50 Days | 0.12 |
| Moving Average 200 Days | 1.97 |
| Change | -0 |
ProPhase Labs Initiates Potential Sale or Strategic Partnership of BE-Smart™ and Advances Crown Medical Collections Initiative
GlobeNewswire Inc.
Feb 03, 2026 12:00 PM GMT
Each Initiative Has the Potential to Drive Significant Liquidity and Strengthen the Company’s Balance Sheet UNIONDALE, NY, Feb. 03, 2026 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (OTC: PRPH) (“ProPhase” or the “Company”), a next-generation biotech, g
Join ProPhase Labs’ Exclusive Live Investor Webinar and Q&A Session on February 3rd
GlobeNewswire Inc.
Feb 02, 2026 1:00 PM GMT
UNIONDALE, NY, Feb. 02, 2026 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (OTC: PRPH) (“ProPhase” or the “Company”) is pleased to invite investors to a webinar on Tuesday, February 3, 2026, at 4:15 p.m. ET. The exclusive event, hosted by RedChip Compani
ProPhase Labs Provides Crown Medical Collections Update; 250+ Insurance Payors Engaged, Approximately 50 Matters in Advanced Settlement Posture
GlobeNewswire Inc.
Jan 26, 2026 12:00 PM GMT
UNIONDALE, NY, Jan. 26, 2026 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (OTC: PRPH) (“ProPhase” or the “Company”), a next-generation biotech, genomics and consumer products company, today provided an operational update on the progress of its Crown Med